Moreover, through the secretion of interleukin 10 (IL-10) and transforming growth factor beta (TGF-β), GSCs are able to suppress the tumor-associated microglia, generating an M2 immunosuppressive phenotype [26]. This evidence concerns the gene IL10 and neoplasm.